COMBINATION OF ANTI-CTLA4 ANTIBODY WITH DIVERSE THERAPEUTIC REGIMENS FOR THE SYNERGISTIC TREATMENT OF PROLIFERATIVE DISEASES

• 收藏
• 分享

专利权人:

BRISTOL-MYERS SQUIBB COMPANY

发明人:

LEE, Francis Y.,JURE-KUNKEL, Maria

申请号：

AU2015203324

公开号：

AU2015203324A1

申请日:

2015.06.17

申请国别(地区):

AU

年份:

2015

代理人:

摘要：

#$%^&*AU2015203324A120150723.pdf#####ABSTRACT A method for the treatment of cancer, comprising the administration to a mammal in need thereof a synergistic, therapeutically effective amount of (i) an anti-CTLA-4 antibody, in addition to one or more diluents, vehicles, excipients, and/or inactive ingredients, and (ii) N(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)- 1 -piperazinyl]-2-methyl-4pyrimidinyl] amino] -5-thiazolecarboxamide (dasatinib), or a pharmaceutically acceptable salt, solvate, or hydrate thereof, in addition to one or more diluents, vehicles, excipients, and/or inactive ingredients.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/